Melio Labs
CEO: Mridu Sinha
Melio is developing a rapid, comprehensive bloodborne pathogen testing platform that can identify 99% of the most common pathogens in hours. Melio aims to profoundly reduce the unnecessary use of antibiotics to improve outcomes, beginning with neonates in the NICU.